ZORAN ZDRAVESKI Insider Profile

4 Followers
ZORAN ZDRAVESKI, Title: Secretary and Chief Legal and Technology Op at Dianthus Therapeutics, holds 4.72K shares in TScan Therapeutics (Ticker: TCRX), holds 128.01K shares in Dianthus Therapeutics (Ticker: DNTH).
tipranks
ZORAN ZDRAVESKI

ZORAN ZDRAVESKI
Dianthus Therapeutics (DNTH)
Title: Secretary and Chief Legal and Technology Op

Ranked #71,616 out of 99,218 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-28.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
99.35%
0.65%
A breakdown of ZORAN ZDRAVESKI's holdings

Insider Roles

Dianthus Therapeutics
(DNTH)
Title: Secretary and Chief Legal and Technology Op
TScan Therapeutics
(TCRX)
Chief Legal and Strategy Officer
Roles that ZORAN ZDRAVESKI holds in companies

Most Profitable Insider Trade

Stock:
TScan Therapeutics
(TCRX)
Rating:Informative Sell
Date:Aug 27, 2024 - Today
Return:+10.40%
The most profitable trade made by ZORAN ZDRAVESKI

ZORAN ZDRAVESKI's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Dianthus Therapeutics
Dec 26, 2019
Title: Secretary and Chief Legal and Technology Op
Uninformative Sell
67.02K
$3.59M
TScan Therapeutics
Aug 27, 2024
Chief Legal and Strategy Officer
Uninformative Buy
531.52K
$23.34K
List of latest transactions for each holding click on a transaction to see ZORAN ZDRAVESKI's performance on stock

ZORAN ZDRAVESKI insider profile FAQ

What is the percentage of profitable transactions made by ZORAN ZDRAVESKI?
The percentage of profitable transactions made by ZORAN ZDRAVESKI is 50%.
    What is the average return per transaction made by ZORAN ZDRAVESKI?
    The average return per transaction made by ZORAN ZDRAVESKI is -28.00%.
      What stocks does ZORAN ZDRAVESKI hold?
      ZORAN ZDRAVESKI holds: DNTH, TCRX stocks.
        What was ZORAN ZDRAVESKI’s latest transaction?
        ZORAN ZDRAVESKI latest transaction was an Uninformative Buy of $531.52K.
          What was ZORAN ZDRAVESKI's most profitable transaction?
          ZORAN ZDRAVESKI’s most profitable transaction was an Informative Sell of TCRX stock on August 27, 2024. The return on the trade was 10.40%.
            What is ZORAN ZDRAVESKI's role in Dianthus Therapeutics?
            ZORAN ZDRAVESKI's role in Dianthus Therapeutics is Title: Secretary and Chief Legal and Technology Op.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.